Questions About Cancer? 1-800-4-CANCER

Cancer Drug Information

  • Posted: 10/05/2006
  • Updated: 07/19/2011

Nelarabine

listen 1  (neh-LAR-uh-been)

This page contains brief information about nelarabine and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Arranon
FDA Approved: Yes

FDA Approval for Nelarabine 2

Use in Cancer

Nelarabine is approved to treat:

Nelarabine is used in patients whose disease has not gotten better with other treatment or has recurred (come back) after earlier chemotherapy.

More About Nelarabine

Definition from the NCI Drug Dictionary 3 - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Nelarabine 4 - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Nelarabine 5 - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.


Back to TopBack to Top



Glossary Terms

chemotherapy (KEE-moh-THAYR-uh-pee)
Treatment with drugs that kill cancer cells.
recurrent cancer (ree-KER-ent KAN-ser)
Cancer that has recurred (come back), usually after a period of time during which the cancer could not be detected. The cancer may come back to the same place as the original (primary) tumor or to another place in the body. Also called recurrence.
T-cell acute lymphoblastic leukemia (T-sel uh-KYOOT LIM-foh-BLAS-tik loo-KEE-mee-uh)
An aggressive (fast-growing) type of leukemia (blood cancer) in which too many T-cell lymphoblasts (immature white blood cells) are found in the bone marrow and blood. Also called precursor T-lymphoblastic leukemia and T-cell acute lymphocytic leukemia.
T-lymphoblastic lymphoma (T-LIM-foh-BLAS-tik lim-FOH-muh)
A type of non-Hodgkin lymphoma in which too many T-cell lymphoblasts (immature white blood cells) are found in the lymph nodes and spleen. It is most common in young men. Also called precursor T-lymphoblastic lymphoma.

Table of Links

1http://www.cancer.gov/PublishedContent/Media/CDR/Media/711218.mp3
2http://www.cancer.gov/cancertopics/druginfo/fda-nelarabine
3http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=43260
4http://www.nlm.nih.gov/medlineplus/druginfo/meds/a607077.html
5http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=43260&idtype=1
6http://www.cancer.gov/cancertopics/druginfo/alphalist
7http://www.cancer.gov/cancertopics/druginfo/drug-page-index
8http://www.cancer.gov/clinicaltrials/learningabout/approval-process-for-cancer-
drugs
9http://www.cancer.gov/cancertopics/factsheet/Therapy/investigational-drug-access